| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/12/2006 | US20060229259 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure |
| 10/12/2006 | US20060229246 Peptide-enhanced transfections |
| 10/12/2006 | US20060229245 Lyophilized HGF preparations |
| 10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 10/12/2006 | US20060229235 Target-binding motif linked to a 3 beta-cholesterylamine derivative membrane-binding element by a beta-alanine subunit; for delivering a protein, peptide, drug, prodrug, lipid, nucleic acid, carbohydrate or small molecule into a target cell via receptor-mediated endocytosis |
| 10/12/2006 | US20060229234 Peptide factor |
| 10/12/2006 | US20060228805 Method of measuring protein solubility, process for producing crystal and apparatus therefor |
| 10/12/2006 | US20060228783 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 10/12/2006 | US20060228781 Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in e.coli |
| 10/12/2006 | US20060228780 Chromatographic method and system for purifying a botulinum toxin |
| 10/12/2006 | US20060228779 Method for producing factor G derived from horseshoe crab |
| 10/12/2006 | US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 10/12/2006 | US20060228777 Animal product free media and processes for obtaining a botulinum toxin |
| 10/12/2006 | US20060228775 Differential expression of nucleic acid molecules |
| 10/12/2006 | US20060228773 Method for preparing recombinant heterocarpine |
| 10/12/2006 | US20060228763 Periostin-based diagnostic assays |
| 10/12/2006 | US20060228761 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 10/12/2006 | US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity |
| 10/12/2006 | US20060228751 Using vector to transform cells with rice Pi2-like disease resistance gene and generating pest resistant rice |
| 10/12/2006 | US20060228725 Method using a nonlinear optical technique for detection of interactions involving a conformational change |
| 10/12/2006 | US20060228724 Assays for screening presence of variant NTE nucleotide sequences in sample; therapeutic agents, ligands, and modulators |
| 10/12/2006 | US20060228715 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 10/12/2006 | US20060228712 Incubating the polynucleotide array with at least one of a labeled polynucleotide derived from a coryneform bacterium, a labeled polynucleotide derived from a mutant of the coryneform bacterium or a labeled polynucleotide,detecting any hybridization, analyzing |
| 10/12/2006 | US20060228710 Novel therapeutic targets in cancer |
| 10/12/2006 | US20060228709 Novel fibulin-like polypeptides |
| 10/12/2006 | US20060228706 Methods of diagnosing and treating diabetes and insulin resistance |
| 10/12/2006 | US20060228705 Cancer-linked gene as target for chemotherapy |
| 10/12/2006 | US20060228697 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure |
| 10/12/2006 | US20060228445 biosynthesis producing vinegar; using the genes of acetobacter to encode a protein involved in shortening the growth promotion and resistance to acetic acid in the presence of a high acetic acid concentration; genetic engineering |
| 10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
| 10/12/2006 | US20060228398 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
| 10/12/2006 | US20060228392 capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast |
| 10/12/2006 | US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 10/12/2006 | US20060228377 Gram-positive bacteria deprived of HtrA protease activity and their uses |
| 10/12/2006 | US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors |
| 10/12/2006 | US20060228365 Protein and gene involved in myocyte differentiation |
| 10/12/2006 | US20060228359 antibody; host cell; hybridoma; |
| 10/12/2006 | US20060228357 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 10/12/2006 | US20060228356 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease |
| 10/12/2006 | US20060228354 Modified ADAMTS4 molecules and method of use thereof |
| 10/12/2006 | US20060228353 PTH1R and PTH3R receptors, methods and uses thereof |
| 10/12/2006 | US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 10/12/2006 | US20060228334 Modified adenoviral fiber with ablated to cellular receptors |
| 10/12/2006 | US20060228332 Assembly and folding of Fc-interferon-beta fusion proteins |
| 10/12/2006 | US20060228331 IL-21 Derivatives and variants |
| 10/12/2006 | US20060228330 Dominant negative proteins and methods thereof |
| 10/12/2006 | US20060228329 Homogeneous preparations of IL-31 |
| 10/12/2006 | US20060228327 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury |
| 10/12/2006 | DE102005014687A1 Zusammensetzung enthaltend ß-Defensin 2 Composition containing ß-defensin 2 |
| 10/12/2006 | CA2604855A1 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 10/12/2006 | CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
| 10/12/2006 | CA2603805A1 Use of rip in treating staphylococcus aureus infections |
| 10/12/2006 | CA2603245A1 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 10/12/2006 | CA2602654A1 Method for shielding functional sites or epitopes on proteins |
| 10/12/2006 | CA2602611A1 Methods of producing proteins having triple-helix structure |
| 10/12/2006 | CA2601857A1 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use |
| 10/11/2006 | EP1710582A2 Suppressor genes |
| 10/11/2006 | EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 10/11/2006 | EP1710313A1 Gene for a heat resistant enzyme of amino acid biosynthetic pathway derived from thermophilic Coryneform bacteria |
| 10/11/2006 | EP1710312A1 Plant-optimized polynucleotide encoding approximately 45 kDa pesticidal protein |
| 10/11/2006 | EP1710311A2 Antigenic polypeptides |
| 10/11/2006 | EP1710310A1 Novel serum type streptococcus mutans and utilization of the same |
| 10/11/2006 | EP1710309A2 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 10/11/2006 | EP1710299A2 Secreted proteins and nucleic acids encoding them |
| 10/11/2006 | EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 10/11/2006 | EP1710253A2 Tumour markers |
| 10/11/2006 | EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 10/11/2006 | EP1710251A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 10/11/2006 | EP1710250A1 Method for preparing serum albumin through heat-treatment in presence of divalent cation |
| 10/11/2006 | EP1709976A1 Emt- inducing agents |
| 10/11/2006 | EP1709973A1 Method of suppressing cancer |
| 10/11/2006 | EP1709447A2 Method and device for detecting feline immunodeficiency virus |
| 10/11/2006 | EP1709421A1 Methods for diagnosis and pronosis of cancers of epithelial origin |
| 10/11/2006 | EP1709183A2 Method of modifying plant phenotypes with nonsymbiotic hemoglobin |
| 10/11/2006 | EP1709179A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 10/11/2006 | EP1709177A2 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 10/11/2006 | EP1709170A2 Expression of mammalian proteins in pseudomonas fluorescens |
| 10/11/2006 | EP1709166A1 Process for the preparation of l-amino acids with amplification of the zwf gene |
| 10/11/2006 | EP1709165A2 Polypeptides of alicyclibacillus |
| 10/11/2006 | EP1709162A2 A novel process of hepatitis a vaccine preparation |
| 10/11/2006 | EP1709161A2 Human therapeutic cells secreting nerve growth factor |
| 10/11/2006 | EP1709157A1 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same |
| 10/11/2006 | EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins |
| 10/11/2006 | EP1709081A2 Fusion polypeptides capable of activating receptors |
| 10/11/2006 | EP1709075A2 Treatment of viral infections |
| 10/11/2006 | EP1709074A1 Cytokine binding domains |
| 10/11/2006 | EP1709073A2 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb) |
| 10/11/2006 | EP1709072A1 Variants of the extracellular domain of bcma and uses thereof |
| 10/11/2006 | EP1709071A1 Glucagon-like peptide-1 analogs with long duration of action |
| 10/11/2006 | EP1709070A1 Peptides for treatment of autoimmune diseases |
| 10/11/2006 | EP1709069A2 Anticariogenic proteins and peptides & saccharides |
| 10/11/2006 | EP1709068A2 Plant activation of insect toxin |
| 10/11/2006 | EP1709067A2 Lawsonia intracellularis subunit vaccines |
| 10/11/2006 | EP1709065A2 A counterion exchange process for peptides |
| 10/11/2006 | EP1709064A2 Dna sequence, and recombinant production of the grass pollen allergen lol p 4 |
| 10/11/2006 | EP1708755A2 Transglutaminase mediated conjugation of peptides |
| 10/11/2006 | EP1708753A1 Use of goat serum for veterinary treatment |
| 10/11/2006 | EP1708748A2 Influenza immunogen and vaccine |
| 10/11/2006 | EP1708746A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |